Jasper Therapeutics (JSPRW) Stock Chart & Stock Price History $0.10 -0.01 (-12.90%) Closing price 03:48 PM EasternExtended Trading$0.09 -0.01 (-10.62%) As of 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Jasper Therapeutics Stock Price Performance The Jasper Therapeutics (JSPRW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 51.05%, with a year-to-date return of -53.29%. In the past month, the stock has decreased 4.95%, reflecting recent market activity. As of the latest close, Jasper Therapeutics traded at $0.11 with a market cap of and volume of 300 shares. Receive JSPRW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-11.00%1 Month Performance-4.95%3 Month Performance-32.95%Year-To-Date Performance-53.29%1 Year Performance-51.05% JSPRW Stock Chart for Monday, July, 7, 2025 JSPRW Chart by TradingView Jasper Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$0.11$0.11$0.11$0.10300 shs$0.0007/03/2025$0.11$0.11+2.18%$0.11$0.10300 shs$0.0007/02/2025$0.10$0.11+14.11%$0.11$0.10350 shs$0.0007/01/2025$0.30$0.10-67.87%$0.11$0.101,266 shs$0.0006/30/2025$0.10$0.30+200.00%$0.12$0.12200 shs$0.0006/27/2025$0.11$0.10-4.76%$0.12$0.12200 shs$0.0006/26/2025$0.10$0.11+5.00%$0.12$0.12204 shs$0.0006/25/2025$0.12$0.10-18.70%$0.13$0.1010,000 shs$0.0006/24/2025$0.10$0.12+23.00%$0.13$0.1010,000 shs$0.0006/23/2025$0.13$0.10-21.26%$0.13$0.1010,085 shs$0.00 Get the Latest News and Ratings for JSPRW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$0.12$0.13+10.43%$0.13$0.123,569 shs$0.0006/19/2025$0.12$0.12$0.14$0.1118,928 shs$0.0006/18/2025$0.12$0.12-3.36%$0.14$0.1118,928 shs$0.0006/17/2025$0.12$0.12-4.03%$0.14$0.082,813 shs$0.0006/16/2025$0.12$0.12+1.64%$0.18$0.0740,009 shs$0.0006/13/2025$0.14$0.12-12.86%$0.18$0.0740,009 shs$0.0006/12/2025$0.11$0.14+25.00%$0.14$0.1028,230 shs$0.0006/11/2025$0.11$0.11-1.75%$0.14$0.091,006 shs$0.0006/10/2025$0.09$0.11+26.25%$0.14$0.093,326 shs$0.0006/09/2025$0.10$0.09-12.33%$0.14$0.09787 shs$0.0006/06/2025$0.12$0.10-10.43%$0.11$0.10724 shs$0.00 Related Companies 180 Life Sciences Stock Chart 4D pharma Stock Chart Aesther Healthcare Acquisition Stock Chart Ainos Stock Chart Alvotech Stock Chart Atlantic Coastal Acquisition Corp. II Stock Chart Biofrontera Stock Chart biote Stock Chart BriaCell Therapeutics Stock Chart Calithera Biosciences Stock Chart Receive JSPRW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:JSPRW) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
